Dihydroergotamine | List of Frontiers open access articles

Original Research

Published on 14 Feb 2025

Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening

in Pharmacology of Anti-Cancer Drugs

Xin Zhang
Jing Zou
Jinghua Ning
Yanhong Zhao
Run Qu
Yuzhe Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500968

2,860 views

Review

Published on 06 Sep 2022

New Approaches to Shifting the Migraine Treatment Paradigm

in Headache

Brian Johnson
Frederick G. Freitag

Frontiers in Pain Research

doi 10.3389/fpain.2022.873179

14,591 views
24 citations

Original Research

Published on 07 Mar 2023

The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients

in Extra-intestinal Microbiome

Min Shen
Ping Ding
Guangxin Luan
Ting Du
Shanshan Deng

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1141274

4,143 views
6 citations

Original Research

Published on 20 Mar 2019

Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature

in Headache and Neurogenic Pain

Najiya Haque
Nauman Tariq

Frontiers in Neurology

doi 10.3389/fneur.2019.00201

4,986 views
8 citations

Original Research

Published on 11 Mar 2015

Relationships among ergot alkaloids, cytochrome P450 activity, and beef steer growth

in Chemical Biology

Charles F. Rosenkrans
Nicholas S. Ezell

Frontiers in Chemistry

doi 10.3389/fchem.2015.00016

5,533 views
7 citations

Original Research

Published on 21 Nov 2023

New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay

in Headache and Neurogenic Pain

Lisa McConnachie
Peter J. Goadsby
Robert E. Vann
Sutapa Ray
Stephen B. Shrewsbury
Sheena K. Aurora

Frontiers in Neurology

doi 10.3389/fneur.2023.1282846

3,621 views
6 citations

Original Research

Published on 17 Dec 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

A. Bérard
S. Strom
D. Albrecht
S. Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

3,212 views
3 citations

Articles

Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening

New Approaches to Shifting the Migraine Treatment Paradigm

The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients

Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature

Relationships among ergot alkaloids, cytochrome P450 activity, and beef steer growth

New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay

Anti-migraine medications safety during pregnancy in the US